(lp0
S'Analyst Activity  Piper Jaffray Companies Reiterates Overweight on Corcept ... Market Exclusive - 7 hours ago Today, Piper Jaffray Companies reiterated its Overweight rating on Corcept Therapeutics Incorporated  with a price target of $18.00.Corcept Therapeutics Incorporated  Upgraded to B at TheStreet - BNB Daily Corcept Therapeutics Incorporated  Plunges 7.8% on March 14 - Equities.com'
p1
aS'Corcept Therapeutics Inc. MarketWatch - Dec 21, 2009 Check out the returns on our 8 Lazy Portfolios that are made up of low-cost buy-and-hold index funds.  How to create your own Lazy Portfolio.'
p2
aS"Corcept Therapeutics: Cushing's Syndrome Is Just The Beginning Seeking Alpha - Oct 11, 2016 Shares are up over 40% since the beginning of the year, but there's plenty of upside left based on growth in the company's core business."
p3
aS'Insider Trading Activity Corcept Therapeutics Incorporated (NASDAQ:CORT ... Market Exclusive - Feb 28, 2017 On 12/5/2012 G Leonard Baker Jr, Director Buy, 87,131 $1.46 with an average share price of $127,211.26 View SEC Filing 11/23/2012 per share and the total transaction amounting to Daniel Bradbury.Corcept Therapeutics Incorporated  Director Sells $22025000.00 in Stock - The Cerbat GemA Look Ahead For 2 Stocks: Global Blood Therapeutics, Inc. , Corcept ... - Post Analyst'
p4
aS"What Analysts are Predicting For Apollo Global Management, LLC , Corcept ... The USA Commerce - 20 hours ago Shares of Apollo Global Management, LLC  dropped -0.13% to $23.32. During the trading on 03/14/2017, Company's stock ranged from $23.07 to $23.40."
p5
aS"Corcept Therapeutics Rose 18% in March. Here's Why. Motley Fool - Apr 6, 2016 What: Shares of Corcept Therapeutics , small-cap biopharma focused on developing products for the metabolic, psychiatric, and oncologic markets, gained more than 18% in March, according to data from S&amp;P Global Market Intelligence."
p6
aS'Corcept: A Profitable Biotech With A Bright Future Seeking Alpha - Jan 27, 2017 Corcept Therapeutics  is my favorite type of biotech company. It has an approved, marketed product with ramping sales, promising pipeline candidates, and is beginning to turn a profit.'
p7
aS'Corcept Therapeutics Incorporated  Moves Higher on Volume Spike for ... Equities.com - Feb 23, 2017 Corcept Therapeutics Incorporated  traded on unusually high volume on Feb. 23, as the stock gained 1.65% to close at $8.65.Stocks Roundup: EP Energy Corporation , Corcept Therapeutics ... - FactsReporterBiotech Stocks Worth a Closer Look: Corcept Therapeutics Incorporated (NASDAQ ... - The Voice Registrar'
p8
aS'Corcept Therapeutics Appoints Renee D. Gala to Board of Directors Marketwired  - Jun 28, 2016 MENLO PARK, CA-- - Corcept Therapeutics Incorporated , a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, psychiatric and&nbsp;...'
p9
aS"Corcept Therapeutics Announces Preliminary Fourth Quarter and Full-Year 2016 ... Marketwired  - Jan 30, 2017 Corcept Therapeutics Incorporated , a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol,&nbsp;...Corcept Therapeutics'  CEO Joseph Belanoff on Q4 2016 Results - Earnings ... - Seeking AlphaAnalysts Trends to Watch: Corcept Therapeutics Incorporated's  - Street Updates"
p10
a.